{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:28:21Z","timestamp":1791646101265,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1925,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbmt.2009.09.013","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T12:43:37Z","timestamp":1253882617000},"page":"S119-S125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"S","title":["Aplastic Anemia: Pathophysiology and Treatment"],"prefix":"10.1016","volume":"16","author":[{"given":"Neal S.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2009.09.013_bib1","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1038\/bmt.2008.293","article-title":"Risk-adapted procedures for HSCT from alternative donors in children with severe aplastic anemia","volume":"42","author":"Fuhrer","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.09.013_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.013_bib3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbmt.2008.07.003","article-title":"Unrelated cord blood transplantation for severe aplastic anemia","volume":"14","author":"Yoshimi","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.09.013_bib4","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.seminhematol.2009.03.008","article-title":"Infections in patients with aplastic anemia","volume":"46","author":"Valdez","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib6","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood-2003-04-1032","article-title":"Recombinant humanized anti-IL2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia","volume":"102","author":"Maciejewski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","article-title":"Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomised trial comparing treatments of aplastic anemia","volume":"101","author":"Frickhofen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib9","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood-2006-07-034272","article-title":"Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)","volume":"109","author":"Socie","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib10","doi-asserted-by":"crossref","first-page":"14483","DOI":"10.1073\/pnas.0605245103","article-title":"Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor","volume":"103","author":"Sloand","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2009.09.013_bib11","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2007-08-019729","article-title":"Telomere maintenance and human bone marrow failure","volume":"111","author":"Calado","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbadis.2009.01.010","article-title":"Dyskeratois congenita, stem cells, and telomeres","volume":"792","author":"Kirwan","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbmt.2009.09.013_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3324\/haematol.2008.002329","article-title":"Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?","volume":"94","author":"Passweg","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.013_bib14","unstructured":"Marsh JCW, Ball SE, Cavenagh J, et\u00a0al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. Published Online: Aug 10 2009."},{"key":"10.1016\/j.bbmt.2009.09.013_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2008.07389.x","article-title":"Outcomes of older patients (\u226560 years) with acquired aplastic anaemia treated with immunosuppressive therapy","volume":"143","author":"Kao","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","article-title":"Minor populations of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia","volume":"107","author":"Sugimori","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V112.11.442.442","article-title":"Telomere Length of peripheral blood leukocytes predicts relapse and clonal evolution after immunosuppressive therapy in severe aplastic anemia","volume":"112","author":"Cooper","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.2008.002170","article-title":"Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis","volume":"94","author":"Gurion","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.013_bib19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2006.06085.x","article-title":"Treatment of severe aplastic anaemia with combined immunosuppression: antithymocyte globulin, ciclosporin and mycophenolate mofetil","volume":"133","author":"Scheinberg","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.13829","article-title":"Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study","volume":"94","author":"Scheinberg","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.013_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2006.06098.x","article-title":"Re-treatment with rabbit antithymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia","volume":"133","author":"Scheinberg","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib22","first-page":"1042","article-title":"Subcutaneous Alemtuzumab is a safe and effective treatment for global or single-lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA","volume":"112","author":"Risitano","year":"2008","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"10.1016\/j.bbmt.2009.09.013_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib24","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bmt.1705669","article-title":"Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia","volume":"40","author":"George","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.09.013_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bbmt.2009.01.023","article-title":"Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia","volume":"15","author":"Horan","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.09.013_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2008.07533.x","volume":"144","author":"Lawler","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.09.013_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.10899","article-title":"Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient","volume":"92","author":"Maury","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.013_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1182\/blood.V100.3.799","article-title":"Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program","volume":"100","author":"Kojima","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.013_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/bbmt.2001.v7.pm11349807","article-title":"Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation","volume":"7","author":"Deeg","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.09.013_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2008.07364.x","article-title":"Double cord blood transplantation in patients with high risk bone marrow failure syndromes","volume":"143","author":"Ruggeri","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:37Z","timestamp":1761057277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109004315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1083879109004315"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4132956.3912054","asserted-by":"object"}]},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aplastic Anemia: Pathophysiology and Treatment","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}